Amgen (AMGN) Long-Term Debt Repayments (2009 - 2026)

Amgen has reported Long-Term Debt Repayments for 16 years, with the latest figure at $833.0 million in Q1 2026.

• On a quarterly basis, Long-Term Debt Repayments fell 66.68% year-over-year to $833.0 million in Q1 2026; TTM through Jun 2026 was $2.3 billion, a 59.07% decrease from a year earlier, with the FY2025 full-year figure at $5.0 billion, up 38.89% from the prior year.
• Long-Term Debt Repayments was $833.0 million for Q1 2026 at Amgen, down from $1.5 billion in the prior quarter.
• The five-year high for Long-Term Debt Repayments was $2.5 billion in Q1 2025, with the low at $704.0 million in Q1 2023.
• Average Long-Term Debt Repayments over 4 years is $1.4 billion, with a median of $1.2 billion recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Long-Term Debt Repayments surged 193.33% in 2024, then slumped 66.68% in 2026.
• Over 4 years, Long-Term Debt Repayments stood at $750.0 million in 2023, then jumped by 193.33% to $2.2 billion in 2024, then sank by 31.82% to $1.5 billion in 2025, then tumbled by 44.47% to $833.0 million in 2026.
• The last three Long-Term Debt Repayments figures came in at $833.0 million (Q1 2026), $1.5 billion (Q3 2025), and $1.0 billion (Q2 2025), per Business Quant data.